Effect of semicrystalline polymers on self-emulsifying solid dispersions of nateglinide: in vitro and in vivo evaluation

References

• Krishnaiah YS. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequiv Avail. 2010;2:28–36.
   Google Scholar
• Ramadhani N, Shabir M, McConville C. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram. Int J Pharm. 2014;475:514–522.
   PubMed Web of Science ®Google Scholar
• Dunn CJ, Faulds D. Nateglinide. Drugs. 2000;60:607–615.
   PubMed Web of Science ®Google Scholar
• Halas CJ. Nateglinide. Am J Health Syst Pharm. 2001;58:1200–1205.
   PubMed Web of Science ®Google Scholar
• Maggi L, Bruni G, Maietta M, et al. I. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: Nanoparticles and co-mixing. Int J Pharm. 2013;454:562–567.
   PubMed Web of Science ®Google Scholar
• Kaleemuddin M, Srinivas P. Lyophilized oral sustained release polymeric nanoparticles of nateglinide. AAPS PharmSciTech. 2013;14:78–85.
   PubMed Web of Science ®Google Scholar
• Maggi L, Bruni G, Maietta M, et al. II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: Co-milling. Int J Pharm. 2013;454:568–572.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Fukushige Y, Matsubara T, et al. Improving water solubility of nateglinide by complexation of β-cyclodextrin. J Therm Anal Calorim. 2015;123:1847–1850.
   Web of Science ®Google Scholar
• He ZQ, Chen XY, Zhong DG, et al. Study on the bioavailability of nateglinide-hydroxypropyl-beta-cyclodextrin complex capsule in rabbits by liquid chromatographic tandem mass spectrometry. Biomed Chromatogr. 2004;18:532–537.
   PubMed Web of Science ®Google Scholar
• Arafa MF, El-Gizawy SA, Osman MA, et al. Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2017;38:9–17.
   Web of Science ®Google Scholar
• Vinod M, Jitendra N, Komal P, et al. Enhancement of solubility with formulation & in-vitro evaluation of oral nateglinide compacts by liquisolid technique. Adv Diabet Metab. 2013;1:57–64.
   Google Scholar
• Ansari MT, Arshad MS, Altaf H, et al. Improvement of solubility, dissolution and stability profile of artemether solid dispersions and self emulsified solid dispersions by solvent evaporation method. Pharm Dev Technol 2016;21:1–9. DOI: 10.1080/10837450.2016.1265554.
   Google Scholar
• Vasanthavada M, Serajuddin AT. Lipid-based self-emulsifying solid dispersions. In: Hauss DJ, editor. Oral lipid-based formulations: enhancing the bioavailability of poorly water-soluble drugs. Boca Raton (FL): CRC Press; 2007. p. 149–184.
   Google Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131–144.
   PubMed Web of Science ®Google Scholar
• Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in poloxamer 407 and PEG 6000: a comparative study of fusion and solvent methods. Powder Technol. 2014;253:98–106.
   Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50:47–60.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 2007;343:228–237.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Shah N, Sandhu H, Choi DS, etet al. Structured development approach for amorphous systems. In: Robert OW III, Alan BW, Dave AM, editors. Formulating poorly water soluble drugs. New York: Springer; 2012. p. 267–310.
   Google Scholar
• Konno H, Handa T, Alonzo DE, et al. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm. 2008;70:493–499.
   PubMed Web of Science ®Google Scholar
• Ilevbare GA, Liu H, Edgar KJ, et al. Maintaining supersaturation in aqueous drug solutions: Impact of different polymers on induction times. Cryst Growth Des. 2012;13:740–751.
   Web of Science ®Google Scholar
• Zhu Q, Harris MT, Taylor LS. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions. Mol Pharm. 2012;9:546–553.
   PubMed Web of Science ®Google Scholar
• Oliveira de EJ, Saraiva J, Albuquerque de S, et al. Solid dispersion of ursolic acid in gelucire 50/13: a strategy to enhance drug release and trypanocidal activity. AAPS PharmSciTech. 2012;13:1–10.
   PubMed Web of Science ®Google Scholar
• Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2012;2:12–17.
   PubMedGoogle Scholar
• Kanakapura B, Penmatsa VK. A review of analytical methods for the determination of nateglinide in pharmaceuticals and biological samples. Pharm Chem J. 2016;49:854–867.
   Web of Science ®Google Scholar
• Sankalia AMF, El-Gizawy SA, Osman MA, et al. Co-crystallization for enhanced dissolution rate of nateglinide: in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2017;38:9–17.
   Web of Science ®Google Scholar
• Guo Y, Shalaev E, Smith S. Physical stability of pharmaceutical formulations: Solid-state characterization of amorphous dispersions. TrAC - Trends Anal Chem. 2013;49:137–144.
   Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27–31.
   PubMedGoogle Scholar
• Zhang Y, Huo M, Zhou J, et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99:306–314.
   PubMed Web of Science ®Google Scholar
• Sanford B, Charles B, editor. Pharmaceutical statistics: practical and clinical applications. New York (YK): Informa Healthcare; 2010.
   Google Scholar
• Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidones. Int J Pharm. 1999;181:143–151.
   PubMed Web of Science ®Google Scholar
• Kolasinac N, Kachrimanis K, Homˇsek I, et al. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 2012;436:161–170.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189–212.
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G, Fathy M. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. Saudi Pharm J. 2009;17:217–225.
   PubMedGoogle Scholar
• Pani NR, Nath LK, Acharya S, et al. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J Therm Anal Calorim. 2012;108:219–226.
   Web of Science ®Google Scholar
• Verheyen S, Blaton N, Kinget R, et al. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm. 2002;249:45–58.
   PubMed Web of Science ®Google Scholar
• Bruni G, Berbenni V, Milanese C, et al. Determination of the nateglinide polymorphic purity through DSC. J Pharm Biomed Anal. 2011;54:1196–1199.
   PubMed Web of Science ®Google Scholar
• Bandari S, Jadav S, Eedara BB, et al. Enhancement of solubility and dissolution rate of loratadine with gelucire 50/13. J Pharm Innov. 2014; 9:141–149.
   Web of Science ®Google Scholar
• Ali W, Williams AC, Rawlinson CF. Stochiometrically governed molecular interactions in drug: poloxamer solid dispersions. Int J Pharm. 2010;391:162–168.
   PubMed Web of Science ®Google Scholar
• Chauhan B, Shimpi S, Paradkar A. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS PharmSciTech. 2005;6:E405–E412.
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066.
   PubMed Web of Science ®Google Scholar
• Tang L, Khan SU, Muhammad NA. Evaluation and selection of biorelevant dissolution media for a poorly water soluble new chemical entity. Pharm Dev Technol. 2001;6:531–540.
   PubMed Web of Science ®Google Scholar
• Schmolka IR. Poloxamers in the pharmaceutical industry. In: Tarcha PJ, editor. Polymers for controlled drug delivery. CRC Press; 1991. p. 189–214.
   Google Scholar
• Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 2009;98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, López-Cervantes M, Naik A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9:339–358.
   PubMed Web of Science ®Google Scholar